Celsion sponsors trial for prostate cancer therapy:
This article was originally published in Clinica
Executive Summary
The University of California at San Francisco (UCSF) has begun a preclinical evaluation of Celsion's microwave-based prostate cancer treatment system, with sponsorship from the company. The system combines focused heat, delivered by microwaves, together with radiation seed implant therapy. Dr Mack Roach, associate professor of radiation therapy at UCSF said: "It is well known that thermotherapy can increase the effectiveness of radiation by a factor of up to two times."